VYNE Therapeutics (VYNE) Stock Chart & Stock Price History → This 1 Biotech Stock has been shocking the markets (From Huge Alerts) (Ad) Free VYNE Stock Alerts $2.79 +0.12 (+4.49%) (As of 12:34 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media VYNE Therapeutics Stock Price Performance5 Day Performance-1.84%1 Month Performance-3.61%3 Month Performance+32.84%6 Month Performance-23.28%Year-To-Date Performance+14.59%1 Year Performance-63.07% Receive VYNE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VYNE Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Huge AlertsThis 1 Biotech Stock has been shocking the marketsSave the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here VYNE Stock Chart for Monday, May, 13, 2024 VYNE Chart by TradingView VYNE Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$2.65$2.67+0.75%$2.77$2.6523,067 shs$37.65 million05/09/2024$2.72$2.65-2.57%$2.77$2.5642,984 shs$37.37 million05/08/2024$2.89$2.72-5.88%$2.92$2.6630,744 shs$38.35 million05/07/2024$2.71$2.89+6.64%$3.10$2.71120,101 shs$40.75 million05/06/2024$2.62$2.71+3.44%$2.75$2.5835,748 shs$38.21 million05/03/2024$2.50$2.62+4.80%$2.77$2.5334,681 shs$36.94 million Get the Latest News and Ratings for VYNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VYNE Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$2.53$2.50-1.19%$2.53$2.4027,242 shs$35.25 million05/01/2024$2.52$2.53+0.40%$2.57$2.5083,587 shs$35.67 million04/30/2024$2.63$2.52-4.18%$2.61$2.4039,432 shs$35.53 million04/29/2024$2.50$2.63+5.20%$2.63$2.5319,218 shs$37.08 million04/26/2024$2.47$2.50+1.21%$2.58$2.4215,899 shs$35.25 million04/25/2024$2.57$2.47-3.89%$2.80$2.4176,764 shs$34.83 million04/24/2024$2.32$2.57+10.78%$2.73$2.30384,748 shs$36.24 million04/23/2024$2.35$2.32-1.28%$2.36$2.2430,168 shs$32.71 million04/22/2024$2.25$2.35+4.44%$2.43$2.2427,675 shs$33.14 million04/19/2024$2.30$2.25-2.17%$2.34$2.2518,999 shs$31.73 million04/18/2024$2.40$2.30-4.17%$2.39$2.2511,091 shs$32.43 million04/17/2024$2.42$2.40-0.83%$2.50$2.3331,165 shs$33.84 million04/16/2024$2.57$2.42-5.84%$2.50$2.3832,965 shs$34.12 million04/15/2024$2.77$2.57-7.22%$2.85$2.4358,525 shs$36.24 million04/12/2024$3.00$2.77-7.67%$2.93$2.6928,561 shs$39.06 million04/11/2024$2.68$3.00+11.94%$3.02$2.56102,769 shs$42.30 million04/10/2024$2.76$2.68-2.90%$2.84$2.5560,847 shs$37.79 million04/09/2024$2.74$2.76+0.73%$2.80$2.7028,419 shs$38.92 million04/08/2024$2.83$2.74-3.18%$2.82$2.6671,401 shs$38.63 million04/05/2024$2.84$2.83-0.35%$2.97$2.7675,891 shs$39.90 million04/04/2024$3.10$2.84-8.39%$3.11$2.81430,435 shs$40.04 million04/03/2024$3.02$3.10+2.65%$3.10$2.9953,581 shs$43.71 million04/02/2024$3.08$3.02-1.95%$3.14$2.91128,660 shs$42.58 million04/01/2024$3.07$3.08+0.33%$3.17$3.01195,578 shs$43.43 million03/29/2024$3.07$3.07$3.09$2.86308,516 shs$43.29 million03/28/2024$2.96$3.07+3.72%$3.09$2.86294,678 shs$43.29 million03/27/2024$2.83$2.96+4.59%$3.08$2.81288,363 shs$41.74 million03/26/2024$2.47$2.83+14.57%$2.85$2.38124,967 shs$39.90 million03/25/2024$2.42$2.47+2.07%$3.16$2.201.17 million shs$34.83 million03/22/2024$2.33$2.42+3.86%$2.42$2.2068,948 shs$34.12 million03/21/2024$2.18$2.33+6.88%$2.33$2.1568,889 shs$32.85 million03/20/2024$2.09$2.18+4.31%$2.18$2.0516,341 shs$30.74 million03/19/2024$1.92$2.09+8.85%$2.18$1.9042,789 shs$29.47 million03/18/2024$2.01$1.92-4.48%$2.03$1.9274,183 shs$27.07 millionDoes this chart look familiar? (Ad)Investors who understand when to get in — and when to get out… Can make a lot of money. Like in the chart, I showed you above…Get all the information here.03/15/2024$2.06$2.01-2.43%$2.09$2.0039,194 shs$28.34 million03/14/2024$2.06$2.06$2.15$2.0269,595 shs$29.04 million03/13/2024$2.10$2.06-1.90%$2.11$2.0252,780 shs$29.04 million03/12/2024$2.14$2.10-1.87%$2.14$1.9780,232 shs$29.61 million03/11/2024$2.25$2.14-4.68%$2.23$2.0749,298 shs$30.17 million03/08/2024$2.32$2.24-3.45%$2.33$2.1866,243 shs$31.58 million03/07/2024$2.35$2.32-1.28%$2.39$2.25121,560 shs$32.71 million03/06/2024$2.25$2.35+4.44%$2.38$2.2199,921 shs$33.14 million03/05/2024$2.28$2.25-1.32%$2.28$2.1659,445 shs$31.41 million03/04/2024$2.22$2.28+2.70%$2.31$2.1073,380 shs$31.82 million03/01/2024$2.23$2.22-0.45%$2.25$2.1190,975 shs$30.99 million02/29/2024$2.33$2.23-4.29%$2.37$2.1682,512 shs$31.13 million02/28/2024$2.37$2.33-1.69%$2.40$2.2670,769 shs$32.53 million02/27/2024$2.35$2.37+0.85%$2.38$2.30142,135 shs$33.09 million02/26/2024$2.26$2.35+3.98%$2.40$2.27106,852 shs$32.81 million02/23/2024$2.17$2.26+4.15%$2.32$2.1481,385 shs$31.55 million02/22/2024$2.17$2.17$2.21$2.1038,299 shs$30.29 million02/21/2024$2.23$2.17-2.69%$2.22$2.1135,917 shs$30.29 million02/20/2024$2.27$2.23-1.76%$2.33$2.1676,401 shs$31.13 million02/19/2024$2.27$2.27$2.28$2.1550,000 shs$31.69 million02/16/2024$2.16$2.27+5.09%$2.28$2.1550,076 shs$31.69 million02/15/2024$2.07$2.16+4.35%$2.25$2.0274,759 shs$30.15 million02/14/2024$2.01$2.07+2.99%$2.07$1.9827,784 shs$28.89 million02/13/2024$2.07$2.01-2.90%$2.07$1.9355,290 shs$28.06 million02/12/2024$2.14$2.07-3.27%$2.14$2.0644,833 shs$28.90 million Related Companies: BOLT Stock Chart EYEN Stock Chart CARA Stock Chart UNCY Stock Chart NXTC Stock Chart LEXX Stock Chart DRRX Stock Chart JAN Stock Chart CASI Stock Chart SNSE Stock Chart Receive VYNE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for VYNE Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VYNE) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThis 1 Biotech Stock has been shocking the marketsHuge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VYNE Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.